Immunodiagnostic Systems Holdings Plc

Immunodiagnostic Systems (IDH)

Company name:Immunodiagnostic Systems Holdings Plc
EPIC:IDHTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00B01YZ052
Market Segment:ASQ1Share Type:DE
WWW Address: 2P
 Price Price Change [%] Bid Offer Open High Low Volume
 270.00 0.0 [0.00] 260.00 280.00 270.00 270.00 265.00 11,625
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 77.72 28.78 0.02 2.70 0.70 100.00 0.26 270.00 - 160.00

Immunodiagnostic Systems Key Figures

(at previous day's close)
Market Cap.77.72m
Shares In Issue28.78m
Prev. Close270.00
PE Ratio100.00 
Dividend Yield0.26%
EPS - basic2.70p
Dividend PS0.70p
Dividend Cover3.86 
Cash Flow PS20.08p
Return On Equity (ROE)1.44%
Operating Margin2.19%
PEG Factor-2.80 
EPS Growth Rate-35.71%
Dividends PS Growth Rate-58.82%
Net Debt-17.10m
Gross Gearing16.10%
Quick Assets39.41m
Net Working Capital39.91m
Intangibles / Fixed Assets59.80%
Turnover PS133.80p
Pre-Tax Profit PS2.93p
Retained Profit PS1.03p
Cash PS96.28p
Net Cash PS70.85p
Net Tangible Asset Value PS *153.30p
Net Asset Value PS192.13p
Spread20.00 (7.14%) 

Immunodiagnostic Systems Balance Sheet


Share Price Performance

Sample Period HighLow
1 week270.00235.00
4 weeks270.00205.00
12 weeks270.00200.00
1 year270.00160.00

Share Price Chart (5 years)

Immunodiagnostic Systems Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week235.0035.0014.89235.000.02268.72
4 weeks205.0065.0031.71205.000.01249.51
12 weeks200.0070.0035.00200.000.00242.20
26 weeks175.0095.0054.29160.000.01204.93
1 year216.0054.0025.00160.000.01193.23
3 years195.0075.0038.46160.000.01238.63
5 years295.00-25.00-8.47112.500.02262.08

Immunodiagnostic Systems Key Management Ratios

Immunodiagnostic Systems Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio4.74 
PE Ratio100.00 
Tobin's Q Ratio 1.16 
Tobin's Q Ratio (excl. intangibles)1.40 
Dividend Yield0.26%
Market-to-Book Ratio1.41 
Price-to-Pre-Tax Profit PS92.30 
Price-to-Retained Profit PS262.56 
Price-to-Cash Flow PS13.45 
Price-to-Sales PS2.02 
Price-to-Net Tangible Asset Value PS1.76 
Price-to-Cash PS2.80 
Net Working Capital PS138.65 
Price Pct to Working Capital PS1.95%
Earnings Yield1.00%
Average PE45.73 
Years in average4 
PE to PE average218.69%

Immunodiagnostic Systems Financial Ratios

(Leverage Ratios)
Debt Ratio5.63%
Debt-to-Equity Ratio0.06 
Debt-to-Equity Ratio (excl. Intgbl)0.07 
Debt-to-Equity Market Value0.04 
Net Gearing-25.94%
Net Gearing (excl. Intangibles)-31.23%
Gross Gearing16.10%
Gross Gearing (excl. Intangibles)19.39%
Gearing Under 1 Year11.10%
Gearing Under 1 Year (excl. Intgbl)13.37%
(Liquidity Ratios)
Net Working Capital to Total Assets60.54%
Current Ratio6.45 
Quick Ratio (Acid Test)5.38 
Liquidity Ratio3.79 
Cash & Equiv/Current Assets58.68%
(Solvency Ratios)
Enterprise Value53.30m
CFO/Attributable Profit7.26 
Total Debt/Equity Market Value0.14 
Total Debt/Sales0.28 
Total Debt/Pre-Tax Profit12.61 
Total Debt10.62m
Total Debt/Net Current Assets0.27%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs6 
Beta (60-Mnth)Beta (36-Mnth)

Immunodiagnostic Systems Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)1.44%
Return On Assets (ROA)1.19%
Net Profit Margin2.07%
Assets Turnover0.58 
Return On Equity (ROE)1.44%
Return On Investment (ROI)1.34%
Dividend Payout Ratio25.93%
Plowback Ratio74.07%
Growth from Plowback Ratio1.05%
Net Income Of Revenues0.77%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.69 
Fixed Assets Turnover2.05 
Current Assets Turnover0.80 
Net Working Capital Turnover 
Inventory Turnover4.76 
(Other Operating Ratios)
Total Assets-to-Sales1.73 
Debt Collection Period111.42Days

Immunodiagnostic Systems Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
19 Jun 2019FinalGBX0.7031/03/201831/03/201918/07/201919/07/201916/08/20190.70
20 Jun 2018FinalGBX1.7031/03/201731/03/201819/07/201820/07/201817/08/20181.70
21 Jun 2017FinalGBX4.0031/03/201631/03/201720/07/201721/07/201718/08/20174.00
22 Jun 2016FinalGBX1.2031/03/201531/03/201621/07/201622/07/201619/08/20161.20
23 Jun 2015FinalGBX3.0031/03/201431/03/201523/07/201524/07/201521/08/20153.00
24 Jun 2014FinalGBX8.5031/03/201331/03/201423/07/201425/07/201422/08/20148.50
17 Jun 2013FinalGBX3.0031/03/201231/03/201324/07/201326/07/201323/08/20133.00
25 Jun 2012FinalGBX2.7531/03/201131/03/201205/09/201207/09/201228/09/20122.75
27 Jun 2011FinalGBX2.5031/03/201031/03/201131/08/201102/09/201129/09/20112.50
12 Jul 2010FinalGBX2.0031/03/200931/03/201018/08/201020/08/201015/09/20102.00
22 Jun 2009FinalGBX1.6531/03/200831/03/200922/07/200924/07/200921/08/20091.65
16 Jul 2008FinalGBX1.5031/03/200731/03/200820/08/200822/08/200812/09/20081.50
16 Jul 2007FinalGBX1.2531/03/200631/03/200722/08/200724/08/200726/09/20071.25
05 Jul 2006FinalGBX1.0031/03/200531/03/200623/08/200625/08/200625/09/20061.00

Immunodiagnostic Systems Fundamentals

 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
pre tax profit-37.02-96.65%1.192.97%0.942.46%0.842.19%m
attributable profit-32.17-83.98%3.017.52%1.233.23%0.802.07%m
retained profit-33.05-86.27%2.666.63%0.050.13%0.300.77%m
eps - basic (p)-109.70 10.20 4.20 2.70 
eps - diluted (p)-109.70 10.20 4.20 2.70 
dividends per share1.20 4.00 1.70 0.70 

Immunodiagnostic Systems Balance Sheet

 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
 31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
fixed assets fixed assets9.6315.45%8.5112.37%7.4711.06%6.8510.39%m
intangibles intangibles9.2114.78%10.4515.20%10.9916.28%11.1816.96%m
fixed investments fixed investments0.290.47%0.330.48%0.350.52%0.661.01%m
current assets - other current assets - other--%--%--%--%m
stocks stocks7.5112.05%7.5711.02%8.3812.40%7.8211.86%m
debtors debtors9.1414.67%10.3815.10%11.8217.50%11.7017.74%m
cash & securities cash & securities26.5542.60%31.5045.82%28.5342.25%27.7142.04%m
creditors - short creditors - short6.5510.51%8.2211.96%7.2610.75%7.3211.10%m
creditors - long creditors - long4.196.72%3.785.51%3.415.04%3.305.00%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves51.6082.77%56.7382.54%56.8784.20%55.3083.90%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Immunodiagnostic Systems Cash Flow Statement

31 Mar 2016 (GBP)31 Mar 2017 (GBP)31 Mar 2018 (GBP)31 Mar 2019 (GBP)
Operating CF8.198.442.525.78m
Pre-Financing CF3.364.81-1.351.35m
Retained CF2.384.27-2.76-0.67m

Immunodiagnostic Systems Brokers

Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Oriel Securities LimitedMarket Maker(MMF)Broker/DealerORELORSNGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191017 20:45:40